Gabriella Miller Kids First Research Act 2.0
Official title: A bill to require certain civil penalties to be transferred to a fund through which amounts are made available for the Gabriella Miller Kids First Pediatric Re… Show full official titleShow less
Official title: A bill to require certain civil penalties to be transferred to a fund through which amounts are made available for the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2365)
Gabriella Miller Kids First Research Act 2.0
This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH).
Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund.
This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1521: Gabriella Miller Kids First Research Act 2.0. 117th Congress. Open America. https://openamerica.io/bill/117-S-1521/
"S. 1521: Gabriella Miller Kids First Research Act 2.0." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-1521/.
S. 1521, 117th Cong. (2026), https://openamerica.io/bill/117-S-1521/.
[S. 1521: Gabriella Miller Kids First Research Act 2.0](https://openamerica.io/bill/117-S-1521/)